Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus (HCQ-IDEAL)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence.
Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.
Full description
This study will be no different from a routine lupus or lupus nephritis clinic visit. During the same visit that a participant routinely does for lupus with their healthcare team, a healthcare team member will discuss the tool that elaborates the benefits vs. risks of lupus medications such as hydroxychloroquine. Participants will complete questionnaires that assesses their understanding of the medication (hydroxychloroquine) before and after they complete the discussion regarding the medication using the tool with the healthcare team member.
Study team members will study the data collected to answer research questions. They will analyze the data and plan better steps improve care quality in lupus.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- age ≥ 18 years
- validated SLE diagnosis
- no absolute contraindication to HCQ (e.g., retinopathy)
- prior HCQ therapy for at least 3-6 months
Exclusion criteria
- participants with other autoimmune diseases
- participants who are not taking HCQ
Trial design
200 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Shivani Garg, MD, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal